Detalles de la búsqueda
1.
Targeted dosing of anti-thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single-arm, phase 2 trial.
Am J Hematol
; 98(11): 1732-1741, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37706580
2.
Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation.
J Immunother Cancer
; 12(1)2024 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184303
3.
High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.
Transplant Cell Ther
; 28(11): 769.e1-769.e9, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973670
4.
Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.
Transplant Cell Ther
; 28(6): 332.e1-332.e10, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314377
5.
Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies.
Ann Transplant
; 27: e937356, 2022 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36217289
Resultados
1 -
5
de 5
1
Próxima >
>>